ALG9-IT1

Across TCGA pan-cancer cohorts, ALG9-IT1 RNA is linked to patient survival in 13 of 34 cancer types, making it the most broadly survival-associated ALG9-IT1 data layer.

The strongest signal is observed in colon adenocarcinoma (COAD), where higher ALG9-IT1 RNA is associated with worse overall survival. In most high-consensus cancer types, elevated ALG9-IT1 expression acts as an unfavorable survival marker, although some lineages such as LAML and HNSC show a favorable association.

COAD, PAAD, and DLBC are the cancer types where ALG9-IT1 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
COAD	OS	Tertile	IV	0.202	0.605	<.001	60	view →
PAAD	OS	Tertile	All	0.186	0.521	.028	45	view →
DLBC	OS	Tertile	III,IV	0.172	0.907	<.001	36	view →
BRCA	DFS	Tertile	All	0.570	1.000	.033	36	view →
TGCT	DFS	Tertile	II,III,IV	0.015	0.919	<.001	36	view →
ACC	DFS	Tertile	IV	0.010	0.383	<.001	27	view →
MESO	DFS	Tertile	III,IV	0.166	0.400	.001	18	view →
LAML	DFS	Median	All	0.706	0.446	.013	18	view →
PRAD	OS	Tertile	All	0.805	0.896	.002	12	view →
SKCM	DFS	Tertile	IV	0.036	0.433	<.001	9	view →
HNSC	DFS	Tertile	II,III,IV	0.357	0.331	.034	9	view →
READ	OS	Tertile	All	0.247	0.704	.012	6	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 13 lineages.

ALG9-IT1–COAD (OS)

Open the COAD breakdown →